Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Rulach
P1.16-26 Safety of SABR (Stereotactic Ablative Body Radiotherapy) for Central Non-Small Cell Lung Cancers (cNSCLC) With 50 Gray in 5 Fractions (50Gy/5f)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
MTE24.02 Small Lung Tumours: High Risk Lesions and Contraindications to Stereotactic Ablative Body Radiotherapy (SABR)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Stereotactic Body Radiotherapy for Large (> 5 Cm) Non–Small-Cell Lung Cancer
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Imaging Follow-Up After Stereotactic Ablative Radiotherapy (SABR) for Lung Tumors
Journal of Radiation Oncology
Oncology
Radiology
Nuclear Medicine
Imaging
P1.16-23 Long-Term Survival Analysis of Surgery in Potential Stereotactic Ablative Radiotherapy Candidates of Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Population-Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for Up to 5 Oligometastases: SABR-5
BMC Cancer
Cancer Research
Oncology
Genetics
Standardization of Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
MS20.02 the Future of Stereotactic Ablative Radiotherapy (SABR)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.16-29 Accelerated Hypofractionated Radiotherapy for Central Lung Tumors Unsuitable for Stereotactic Body Radiotherapy or Concurrent CRT
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Feasibility of Stereotactic Body Radiotherapy for Locally-Advanced Non-Small Cell Lung Cancer
Clinical and Translational Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
